Bacillus Coagulans

Wadatacce

• Yiwuwar tasiri ga ...
• Evidencearancin shaida don kimanta inganci don ...
• Kariya & Gargaɗi na Musamman:

Bacillus coagulans wani nau'in kwayoyin cuta ne. Ana amfani da shi kamar wancan zuwa lactobacillus da sauran maganin rigakafi azaman kwayoyin "amfani".

Mutane suna daukar Bacillus coagulans don cututtukan hanji (IBS), gudawa, gas, cututtukan iska, da sauran yanayi, amma babu kyakkyawar shaidar kimiyya don tallafawa waɗannan amfani.

Bacillus coagulans yana samar da lactic acid kuma galibi ana rarraba shi azaman lactobacillus. A zahiri, ana sayar da wasu kayayyakin kasuwanci da ke ƙunshe da Bacagus coagulans a matsayin Lactobacillus sporogenes. Ba kamar ƙwayoyin cuta na lactic acid kamar lactobacillus ko bifidobacteria, Bacillus coagulans suna samar da ƙwayoyi. Spores muhimmin mahimmanci ne wajen gaya wa Bacillus coagulans baya ga sauran kwayoyin lactic acid.

Magunguna na Compwararren Bayanan Bayanai ƙimar tasiri bisa ga shaidar kimiyya bisa ga mizani mai zuwa: Inganci, Mai yuwuwa Mai Yiwuwa, Yiwuwar Tasiri, Yiwuwar Mara Inganci, Mai yiwuwa Mara Inganci, Mara Inganci, da suarancin Shaida don Rate.

Effectivenessimar tasiri don BACILLUS COAGULANS sune kamar haka:

Yiwuwar tasiri ga ...

• Rashin lafiya na dogon lokaci na manyan hanji wanda ke haifar da ciwon ciki (ciwon mara na hanji ko IBS). Bincike na asibiti ya nuna cewa shan Bacillus coagulans a kullum na tsawon kwanaki 56-90 na inganta rayuwa kuma yana rage kumburin ciki, amai, ciwon ciki, da yawan yin hanji a cikin mutanen da ke fama da gudawa-galibin IBS. Sauran bincike na asibiti sun nuna cewa shan wani takamaiman kayan hadin (Colinox, DMG Italia SRL) dauke da Bacillus coagulans da simethicone sau uku a kullum na tsawon makonni 4 yana inganta kumburin ciki da rashin jin daɗi ga mutanen da ke tare da IBS.

Evidencearancin shaida don kimanta inganci don ...

• Ciwan hanta (cirrhosis). Mutanen da ke fama da cutar hanta za su iya kamuwa da wata cuta da ake kira peritonitis na kwayar cuta, ko SBP. Binciken farko ya nuna cewa shan kwayar cuta mai dauke da kwayoyin Bacillus coagulans da wasu kwayoyin sau uku a rana, tare da maganin norfloxacin, ba ya rage barazanar mutum na kamuwa da cutar SBP.
• Maƙarƙashiya. Binciken farko ya nuna cewa shan Bacillus coagulans sau biyu a rana na tsawon makonni 4 na iya inganta ciwan ciki da rashin jin daɗi ga mutanen da ke da alaƙar ciki.
• Gudawa. Binciken farko a jarirai watanni 6-24 da haihuwa tare da gudawa ya nuna cewa shan Bacillus coagulans na tsawon kwanaki 5 baya rage gudawa. Amma shan Bacillus coagulans yana da alama yana inganta gudawa da ciwon ciki ga manya.
• Gudawa da cutar rotavirus ta haddasa. Binciken farko a jarirai sabbin haihuwa ya nuna cewa shan Bacillus coagulans a kullum tsawon shekara guda yana rage barazanar yaro na kamuwa da cutar rotavirus.
• Gas (flatulence). Shaida ta farko a cikin mutanen da suke da gas bayan sun ci abinci ya nuna cewa shan wani takamaiman haɗin haɗin da ke ɗauke da Bacillus coagulans da kuma haɗakar enzymes kowace rana tsawon makonni 4 ba ya inganta kumburi ko gas.
• Rashin narkewar abinci (dyspepsia). Binciken farko ya nuna cewa shan Bacillus coagulans a kullum na tsawon makwanni 8 na iya rage alamomin burping, belching, da kuma dandano mai tsami. Sauran bincike sun nuna cewa shan Bacillus coagulans sau biyu a rana tsawon sati 4 yana rage ciwon ciki da kumburin ciki.
• Yawan ƙwayoyin cuta a cikin ƙananan hanji. Shaidun farko sun nuna cewa amfani da takamaiman maganin rigakafi (Lactol, Bioplus Life Sciences Pvt. Ltd.) wanda ke dauke da Bacillus coagulans da fructo-oligosaccharides kowace rana na tsawon kwanaki 15 na kowane wata na tsawon watanni 6 na iya rage yawan ciwon ciki da iskar gas cikin mutane masu cutar kwayar cuta mai cutarwa a cikin hanji.
• Rheumatoid amosanin gabbai (RA). Binciken farko ya nuna cewa shan Bacillus coagulans kowace rana tsawon kwanaki 60 ban da magani na yau da kullun na iya rage radadi, amma ba ya rage yawan wuraren raɗaɗi ko kumburi a cikin mutanen da ke da RA. Bacillus coagulans kuma baya inganta ikon aiwatar da ayyukan yau da kullun a cikin mutane tare da RA.
• Cutar mai tsanani a cikin jarirai wanda bai isa haihuwa ba (necrotizing enterocolitis ko NEC). Yaran da aka haifa da wuri ko kuma suke da nauyin mara nauyi suna cikin haɗarin kamuwa da cuta mai tsanani a cikin hanjin da ake kira necrotizing enterocolitis. Binciken farko a cikin wadannan jarirai ya nuna cewa shan Bacillus coagulans a kullum har zuwa barin asibiti baya hana nerorozing enterocolitis ko mutuwa. Koyaya, shan Bacillus coagulans yana ƙara yawan jariran da ke iya jure abinci.
• Ofara kitse a cikin hanta a cikin mutanen da ke shan kaɗan ko kuma ba giya ba (cutar hanta mai haɗari ko NAFLD).
• Rigakafin cutar kansa.
• Kamuwa da cututtukan ciki ta hanyar ƙwayoyin cuta da ake kira Clostridium wuya.
• Matsalar narkewar abinci.
• Cututtuka na narkewa wanda zai haifar da ulcers (Helicobacter pylori ko H. pylori).
• Immarfafa tsarin rigakafi.
• Busa lokaci mai tsawo (kumburi) a cikin hanyar narkewar abinci (cututtukan hanji mai kumburi ko IBD).
• Kamuwa da hanyoyin iska.
• Sauran yanayi.

Ana buƙatar ƙarin shaida don kimanta maganin Bacillus don waɗannan amfani. Babu wadataccen bayani don sanin yadda Bacillus coagulans zasu iya aiki don dalilai na likita. Wasu bincike sun nuna cewa Bacagus coagulans na iya kara karfin garkuwar jiki da kuma rage kwayoyin cuta.

Lokacin shan ta bakin: Bacillus coagulans shine MALAM LAFIYA lokacin da aka sha ta baki. Bincike ya nuna cewa ana iya amfani da Bacagus coagulans a cikin allurai na mallaka biliyan biyu (CFUs) kowace rana cikin aminci har zuwa watanni 3. Ana iya amfani da ƙananan allurai na Bacillus coagulans har zuwa miliyan 100 CFUs kowace rana cikin aminci har zuwa shekara 1.

Kariya & Gargaɗi na Musamman:

Ciki da shan nono: Babu wadataccen ingantaccen bayani game da amincin shan Bacillus coagulans idan kuna ciki ko ciyar da nono. Kasance a gefen aminci ka guji amfani.

Yara: Bacillus coagulans shine MALAM LAFIYA lokacin da aka sha bakin ta jarirai da yara. Wasu bincike sun nuna cewa Bacillus coagulans har zuwa miliyan 100 na rukunin mallaka (CFUs) a kowace rana za a iya amfani da jarirai cikin aminci har zuwa shekara guda.

Matsakaici

Yi hankali da wannan haɗin.

Magungunan rigakafi

Ana amfani da maganin rigakafi don rage kwayoyin cuta masu illa a jiki. Magungunan rigakafi na iya rage sauran kwayoyin cuta a jiki. Shan maganin rigakafi tare da Bacillus coagulans na iya rage fa'idar amfanin Bacillus coagulans. Don kaucewa wannan haɗin gwiwar, ɗauki kayan Bacillus coagulans aƙalla awanni 2 kafin ko bayan maganin rigakafi.

Magunguna waɗanda ke rage tsarin garkuwar jiki (Immunosuppressants)

Bacillus coagulans na iya kara ayyukan garkuwar jiki. Shan coagulans na Bacillus tare da magungunan da ke rage ayyukan garkuwar jiki na iya rage tasirin waɗannan magunguna.
Wasu magungunan da ke rage ayyukan garkuwar jiki sun hada da azathioprine (Imuran), basiliximab (Simulect), cyclosporine (Neoral, Sandimmune), daclizumab (Zenapax), muromonab-CD3 (OKT3, Orthoclone OKT3), mycophenolate (CellCept), tacrolimus (Frog) Prograf), sirolimus (Rapamune), prednisone (Deltasone, Orasone), corticosteroids (glucocorticoids), da sauransu.

Babu sanannun hulɗa tare da ganye da kari.

Babu sanannun hulɗa da abinci.

An yi nazarin ƙwayoyi masu zuwa a cikin binciken kimiyya:

MAGABATA

DA BAKI:

• Don cuta na dogon lokaci na manyan hanji wanda ke haifar da ciwon ciki (ciwon mara na hanji ko IBS): Bacillus coagulans (Lactospore, Sabinsa Corporation) biliyan biliyan 2 da suka kafa ƙungiyoyi (CFUs) kowace rana tsawon kwanaki 90. Bacillus coagulans (GanedenBC30, Ganeden Biotech Inc.) miliyan 300 zuwa CFU biliyan biliyan 2 kowace rana tsawon makonni 8. Hakanan, an yi amfani da takamaiman samfurin haɗin gwiwa (Colinox, DMG Italia SRL) wanda ke ɗauke da Bacillus coagulans da simethicone bayan kowane cin abinci sau uku kowace rana don makonni 4.

B. Coagulans, Bacillus Bacteria, Bacillus Probiotics, Bacteus Bacbio, Bactéries à Gram Positif Sporogènes, Bactérie Gram Positive en Forme de Bâtonnet, Gram Positive Spore-Forming Rod, L. Sporogenes, Lactobacillus Sporogenes, Lactobacillus, Lakarin Baccin, Kirkirar Lactobacillus.

Don ƙarin koyo game da yadda aka rubuta wannan labarin, da fatan za a duba Magunguna na Compwararren Bayanan Bayanai hanya.

1. Kumar VV, Sudha KM, Bennur S, Dhanasekar KR. Mai yiwuwa, bazuwar, lakabin budewa, nazarin kwatankwacin wuribo na Bacillus coagulans GBI-30,6086 tare da enzymes masu narkewa cikin inganta rashin narkewar abinci a cikin yawan masu tsufa. J Kula da Lafiya ta Iyali. 2020; 9: 1108-1112. Duba m.
2. Chang CW, Chen MJ, Shih SC, da sauransu. Bacillus coagulans (PROBACI) wajen magance matsalar maƙarƙashiya mafi rinjaye rikicewar hanji. Magunguna (Baltimore). 2020; 99: e20098. Duba m.
3. Soman RJ, Swamy MV. Mai yiwuwa, bazuwar, makafi biyu, mai sarrafa wuribo, nazarin rukuni-rukuni don kimanta inganci da amincin SNZ TriBac, wani nau'in Bacillus mai nau'in uku mai haɗuwa don rashin jin daɗin ciwon hanji. Int J Colorectal Dis. 2019; 34: 1971-1978. Duba m.
4. Abhari K, Saadati S, Yari Z, et al. Sakamakon Bacillus coagulans ƙarin ga marasa lafiya tare da cutar hanta mai haɗari mai haɗari: Tsarin bazuwar, sarrafa wuribo, gwajin asibiti. Clin Nutr ESPEN. 2020; 39: 53-60. Duba m.
5. Maity C, Gupta AK. Mai yiwuwa, shiga tsakani, bazuwar, makafi biyu, nazarin asibiti mai sarrafa wuribo don kimanta inganci da amincin Bacillus coagulans LBSC wajen kula da cutar gudawa mai saurin ciwon ciki. Eur J Clin Pharmacol. 2019; 75: 21-31. Duba m.
6. Hun L. Bacillus coagulans ya inganta ciwan ciki da kumburin ciki ga marasa lafiya tare da IBS. Bayanin Med 2009; 121: 119-24. Duba m.
7. Yang OO, Kelesidis T, Cordova R, Khanlou H. Immunomodulation na antiretroviral miyagun ƙwayoyi-kawar da kwayar cutar HIV-1 na yau da kullum a cikin kwayar maganin rigakafi mai sau biyu. Cutar Kanjamau ta sake komawa baya ta 2014; 30: 988-95. Duba m.
8. Dutta P, Mitra U, Dutta S, et al. Gwajin gwaji na asibiti na Lactobacillus sporogenes (Bacillus coagulans), wanda aka yi amfani dashi azaman probiotic a aikin asibiti, kan cutar gudawa mai saurin ruwa a cikin yara. Trop Med Int Health 2011; 16: 555-61. Duba m.
9. Endres JR, Clewell A, Jade KA, et al. Tantance tsaro game da shirye-shiryen mallakar kayan abinci na zamani, Bacillus coagulans, a matsayin kayan abinci. Abincin Chem Toxicol 2009; 47: 1231-8. Duba m.
10. Kalman DS, Schwartz HI, Alvarez P, et al. Mai yiwuwa, bazuwar, makafi biyu, gwajin gwaji na rukuni-rukuni mai sarrafa wuribo don kimanta tasirin samfurin Bacillus na coagulans akan alamun gas na hanji mai aiki. BMC Gastroenterol 2009; 9: 85. Duba m.
11. Dolin BJ. Hanyoyin mallakar Bacillus na coagulans na kamfani kan alamun bayyanar cututtukan ciki-mafi yawan ciwon hanji. Hanyar Nemo Exp Clin Pharmacol 2009; 31: 655-9. Duba m.
12. Mandel DR, Eichas K, Holmes J. Bacillus coagulans: ingantaccen maganin ci gaba don kawar da alamun cututtukan cututtukan zuciya kamar yadda bazuwar, gwajin sarrafawa. BMC ya haɓaka madadin Med na 2010; 10: 1. Duba m.
13. Sari FN, Dizdar EA, Oguz S, et al. Magungunan maganganu na baka: Lactobacillus sporogenes don rigakafin necrotizing enterocolitis a cikin ƙananan ƙananan ƙananan yara: gwajin bazuwar, gwajin sarrafawa. Eur J Clin Nutr 2011; 65: 434-9. Duba m.
14. Riazi S, Wirawan RE, Badmaev V, Chikindas ML. Halin halayen lactosporin, wani sabon furotin mai dauke da kwayar cutar wanda Bacillus coagulans ATCC 7050 ya samar.J Appl Microbiol 2009; 106: 1370-7. Duba m.
15. Pande C, Kumar A, Sarin SK. Ofari na maganin rigakafi zuwa norfloxacin ba ya inganta inganci a cikin rigakafin kwayar cutar kwayar cutar da ba ta dace ba: gwajin makirci mai ruɓi mai sau biyu. Eur J Gastroenterol Hepatol 2012; 24: 831-9. Duba m.
16. Majeed M, Nagabhushanam K, Natarajan S, et al. Bacillus coagulans MTCC 5856 kari a cikin kula da gudawa mafi yawan cututtukan hanji: wani makauniyar wuri mai rikitarwa mai saurin sarrafawa ta asibiti. Nutr J 2016; 15:21. Duba m.
17. Chandra RK. Hanyoyin Lactobacillus akan tasirin da tsananin tsananin zazzabin rotavirus cikin jarirai. Nazarin binciken makanta mai sau biyu. Nutr Sakamakon 2002; 22: 65-9.
18. De Vecchi E, Drago L. Lactobacillus sporogenes ko Bacillus coagulans: kuskuren ganewa ko mislabeling? Int J Tsarin rigakafin rigakafi 2006; 1: 3-10.
19. Jurenka JS. Bacillus coagulans: Monograph. Madadin Rev 2012; 17: 76-81. Duba m.
20. Urgesi R, Casale C, Pistelli R, et al. Abubuwan da ke faruwa Gwajin gwajin-wuri mai sau biyu mai rikitarwa akan inganci da amincin ƙungiyar simethicone da Bacillus coagulans (Colinox) a cikin marasa lafiya da cututtukan hanji. Eur Rev Med Pharmacol Sci 2014; 18: 1344-53. Duba m.
21. Khalighi AR, Khalighi MR, Behdani R, et al. Kimantawa akan ingancin probiotic akan jiyya ga marasa lafiya da ƙananan ƙwayoyin cuta na hanji (SIBO) - binciken matukin jirgi. Indiya J Med Res. 2014 N ov; 140: 604-8. Duba m.
22. Czaczyk K, Tojanowska K, Mueller A. Ayyukan Antifungal na Bacillus coagulans akan Fusarium sp. Dokar Microbiol Pol 2002; 51: 275-83. Duba m.
23. Donskey CJ, Hoyen CK, Das SM, et al. Tasirin maganin coagulans na Bacillus na baka akan yawaitar enterococci mai jurewa cikin kwandon beraye masu mulkin mallaka. Lett Appl Microbiol 2001; 33: 84-8. Duba m.
24. Hyronimus B, Le Marrec C, Urdaci MC. Coagulin, ƙananan ƙananan ƙwayoyin cuta kamar ƙwayoyin cuta waɗanda Bacillus coagulans I4 suka samar. J Appl Microbiol 1998; 85: 42-50. Duba m.
25. Magungunan rigakafi don cututtukan cututtukan kwayoyin cuta. Takardar Pharmacist / Wasikar Marubuci 2000; 16: 160103.
26. Duc LH, Hong HA, Barbosa TM, et al. Hali na maganin rigakafin Bacillus da ke akwai don amfanin ɗan adam. Abubuwan Tsarin Microbiol na 2004; 70: 2161-71. Duba m.
27. Velraeds MM, van der Mei HC, Reid G, Busscher HJ. Rashin hana mannewa na farko na uropathogenic Enterococcus faecalis ta masu nazarin halittu daga keɓaɓɓiyar keɓaɓɓu na Lactobacillus. Appl kewaye Microbiol 1996; 62: 1958-63. Duba m.
28. McGroarty JA. Amfani da lactobacilli a cikin kwayar cutar urogenital ta mata. FEMS Immunol Med Microbiol 1993; 6: 251-64. Duba m.
29. Reid G, Bruce AW, Cook RL, et al. Tasiri kan cututtukan urogenital na maganin rigakafi don kamuwa da cutar yoyon fitsari. Scand J Infect Dis 1990; 22: 43-7. Duba m.

Binciken na ƙarshe - 12/04/2020